Ochronosis / Alkaptonuria

Ochronosis is the muscoskeletal manifestation of alkaptonuria – a rather rare (one in 200,000 births) inherited disorder of protein metabolism characterized by an inability of the body to metabolize the amino acids tyrosine and phenylalanine. It affects especially the large joints (hip, knees and vertebral column) by a progressive degenerative arthrosis.

The outward signs are the ocular (eye) and the skin pigmentations, the genito-urinary calculi (stones) and cardiovascular ochronosis (especially the aortic valve). The symptoms mostly begin within the third or fourth decade.

It was Scribonius who described the first known case of ochronosis in 1584. He mentioned a schoolboy who passed urine black as ink. In 1902, Albrecht and Zdareck discovered the link with alkaptonuria. The incidence of alkaptonuria is 1 per million with the highest prevalence in Slovakia by inbreeding.

There is no cure for ochronotic arthropathy. The enzyme deficiency is as yet untreatable (gene therapy in the future?) Some physicians prescribe high doses of ascorbic acid to prevent the interaction of the ochronotic pigment with the tissues. Unfortunately, the progress of the disease is not interrupted by this treatment. There only exists a symptomatic treatment: analgetics, NSAID, physical therapy, orthopaedic supports and intra-articular corticoid infiltration, especially in the knee. Finally, arthroplasty of the hip and knee is often necessary.

 

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.